Cholinergic Functioning, Cognition, and Anticholinergic Medication Burden in Schizophrenia
Current Topics in Behavioral Neurosciences · 2022
DOI: 10.1007/7854_2022_400 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Current Topics in Behavioral Neurosciences, 2022. Verfasst von Yash B Joshi. Beteiligte Einrichtung: Desert Pacific Mental Illness Research Education and Clinical Center, VA San Diego Healthcare System, San Diego, CA, USA. yajoshi@health.ucsd.edu. Hauptthemen laut MEDLINE: Schizophrenia, Cognitive Dysfunction, Cognition Disorders. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 97 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Desert Pacific Mental Illness Research Education and Clinical Center, VA San Diego Healthcare System, San Diego, CA, USA. yajoshi@health.ucsd.edu.
- Department of Psychiatry, University of California, San Diego, La Jolla, CA, USA. yajoshi@health.ucsd.edu.
Zitieren
APA
Joshi, Y. B. (2022). Cholinergic Functioning, Cognition, and Anticholinergic Medication Burden in Schizophrenia. Current Topics in Behavioral Neurosciences. https://doi.org/10.1007/7854_2022_400
Vancouver
Joshi YB. Cholinergic Functioning, Cognition, and Anticholinergic Medication Burden in Schizophrenia. Current Topics in Behavioral Neurosciences. 2022. doi:10.1007/7854_2022_400
BibTeX
@article{Joshi2022,
author = {Joshi, Yash B},
title = {Cholinergic Functioning, Cognition, and Anticholinergic Medication Burden in Schizophrenia},
journal = {Current Topics in Behavioral Neurosciences},
year = {2022},
doi = {10.1007/7854_2022_400}
}
EUVIMED